Form 4: KeyCorp CEO Christopher Gorman Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Christopher Gorman, Chairman and CEO of KeyCorp, reports transactions involving common shares and restricted stock units, including acquisitions, disposals, and vesting of units.
Summary
- Christopher Gorman, the Chairman and CEO of KeyCorp, filed a Form 4 detailing changes in his beneficial ownership of KeyCorp securities.
- On February 17, 2025, Gorman acquired 115,514 common shares through vesting of restricted stock units.
- He also disposed of 45,559 common shares at a price of $17.72.
- Following these transactions, Gorman directly owns 869,721 common shares.
- Gorman also indirectly owns 200,000 common shares and 126,645 common shares through a grantor retained annuity trust (GRAT).
- He also indirectly owns 5,060 shares through a 401(k) plan.
- Gorman was granted 139,959 options to buy common shares on February 17, 2025, which vest in four equal annual installments beginning on February 17, 2026, and expire on February 17, 2035.
- He also directly owns various amounts of restricted stock units that vest over time.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing showing transactions related to executive compensation. The disposal of shares is slightly negative, but the overall impact is balanced by the acquisition of shares through vesting.
Positives
- The acquisition of shares through vesting of restricted stock units indicates continued alignment of the CEO's interests with those of the shareholders.
Negatives
- The disposal of 45,559 common shares by the CEO could be interpreted negatively by some investors, although the reason for the disposal is not specified.
Risks
- The Form 4 filing itself doesn't inherently present risks, but market perception of the transactions could influence the stock price.
- Unspecified reasons for share disposals by key executives can sometimes create uncertainty among investors.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of restricted stock units and options suggest continued long-term incentives for the CEO.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are standard practice in the financial services industry.
- Vesting schedules of four years are also common to incentivize long-term performance.
- Comparing Gorman's holdings and transactions to those of CEOs at peer institutions like Bank of America (BAC) or Citigroup (C) would provide a more comprehensive assessment of his equity stake relative to industry norms.
Stakeholder Impact
- The transactions reported may influence investor perception of KeyCorp's stock.
- Employees participating in the Discounted Stock Purchase Plan are indirectly affected by changes in the stock price.
Key Dates
| Date | Description |
|---|---|
| February 15, 2021 | Date of grant for 20,626 restricted stock units vesting in four equal annual installments beginning on February 17, 2022. |
| February 14, 2022 | Date of grant for 24,558 restricted stock units vesting in four equal annual installments beginning on February 17, 2023. |
| February 17, 2023 | Date of grant for 30,978 restricted stock units vesting in four equal annual installments beginning on February 17, 2024. |
| March 2024 | Start date for accruing common shares under the KeyCorp Second Amended and Restated Discounted Stock Purchase Plan. |
| December 2024 | End date for accruing dividend-equivalent restricted stock units. |
| February 14, 2025 | Date as of which 5,060 shares are reported as indirectly owned through a 401(k) plan. |
| February 16, 2024 | Date of grant for 39,352 restricted stock units vesting in four equal annual installments beginning on February 17, 2025. |
| February 17, 2025 | Date of transactions including acquisition of common shares, disposal of common shares, grant of restricted stock units, and grant of options to buy common shares. |
| February 17, 2026 | Start date for vesting of restricted stock units and options granted on February 17, 2025. |
| February 17, 2035 | Expiration date of options to buy common shares granted on February 17, 2025. |
| February 19, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.